Jonathan S. Wall, PhD^1*, Stephen J. Kennel, PhD^1*, Alan Stuckey, CNMT^1*, Bryan Whittle, CNMT^2*, Joseph W. Jackson, PhD^1*, Angela D. Williams, MS^1*, Trevor Hancock, PhD^1*, R. Eric Heidel, PhD^1*, Muddassir Mehmood, MD^2*, Anne Kassira, MD^2*, Ronald H. Lands, MD¹, Hannah Watson^2*, Rebecca Hung, MD, PhD^3* and Emily B Martin, PhD^1*

¹University of Tennessee Health Science Center College of Medicine, Knoxville, TN
²University of Tennessee Medical Center, Knoxville, TN
³Vanderbilt University Medical Center, Nashville, TN

John Hanna, MD¹, Ryan Brown, MD^1*, Zain Ali Burney, MD^1*, Kawther Abdallah, MD^1*, Jason Valent, MD², Christy J. Samaras, DO², Faiz Anwer, MD², Jack Khouri, MD², Louis Williams, MD², Shahzad Raza, MD², Willem Van Heeckeren, MD, PhD^2* and Sandra Mazzoni, DO^2*

¹Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
²Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Victor H. Jimenez-Zepeda, MD¹, Irwindeep Sandhu, MD^2*, Michael P. Chu, MD³, Kathryn Rankin^4*, Arleigh McCurdy, MD⁵, Hyra Sapru, MD⁵, Christopher Cipkar, MD, BSc^5*, Edward Koo^5*, Benjamin Patrick^5*, Sarah Albert^5*, Meriem Henia^6*, Christopher McCudden^7* and Alissa Visram, MD, MPH⁸

¹Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada
²University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada
³Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
⁴Cancer Care Alberta, Alberta Health Services, Edmonton, AB, Canada
⁵The Ottawa Hospital, Ottawa, ON, Canada
⁶University of Ottawa, Ottawa, ON, Canada
⁷Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada
⁸Division of Hematology, The Ottawa Hospital Research Institute, Ottawa, ON, Canada

Sandra CM Quinn, PhD, BA^1* and Danielle Romaniuk^2*

¹Research and Advocacy, Myeloma UK, Edinburgh, SCO, United Kingdom
²Research and Advocacy, Myeloma UK, Edinburgh, Scotland, United Kingdom

Divaya Bhutani, MD^1,2, Rajshekhar Chakraborty, MD², Suzanne Lentzsch, MD, PhD^2,3, Meghan Sise, MD, MS^4*, Elizabeth Shelton^5*, Emily Simone^6*, Naomi Sender^7*, Sherley Mejia^8* and Shayan Shirazayan^9*

¹Herbert Irving Comprehensive Cancer Center, Columbia University medical center, New York, NY
²Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
³Columbia University Irving Medical Center, New York Presbyterian, New York, NY
⁴Division of Nephrology, Massachusetts General Hospital, Boston, MA
⁵columbia university medical center, New York
⁶Columbia University Medical Center, New YorK
⁷Columbia University, New York, NY
⁸Mass General Hospital, Boston
⁹Columbia University Medical Center, New York

Romain Stammler, MD^1*, Yannick Dieudonné^2*, Florence Delestre^3*, Boris Sorin^4*, Bertrand Dunogué^3*, Silene Knapp^5*, Gregoire Martin De Fremont^6*, Benjamin Fournier, MD; PhD^7*, Anthony Vanjak^6*, Veronique Meignin, MD^8*, Emilie Corvilain, MD^9*, Emmanuel Lafont^10*, Thibault Mahevas^11*, Laurence Gerard, MD^12*, Lionel Galicier^13*, Celeste Lebbe^14*, Eric Oksenhendler^13*, Sylvain Latour^15* and David Boutboul, MD, PhD^1,16*

¹Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute, Paris, France
²Strasbourg University Hospital, Strasbourg, FRA
³Internal Medicine, Hopital Cochin Université Paris Cité, Paris, France
⁴Internal Medicine, Hopital Cochin Université Paris Cité, Paris, FRA
⁵Hematology, Hopital Cochin, Paris, FRA
⁶U976 HIPI, Paris, FRA
⁷Necker Hospital (APHP), Paris, France
⁸Pathology, Hopital Saint-Louis, PARIS, FRA
⁹Hôpital Saint-Louis, APHP, Paris, France
¹⁰Assistance Publique -hopitaux De Paris, Paris, FRA
¹¹Dermatology, Hôpital Saint Louis, Paris, France
¹²Hôpital Saint-Louis, Paris, France
¹³Service d'Immunopathologie Clinique, Saint Louis hospital, AP-HP, Paris, France
¹⁴Hopital Saint Louis, Paris, FRA
¹⁵Instutut IMAGINE, Hôpital Necker, Paris, FRA
¹⁶Department of Hematology, Hôpital Cochin, AP-HP, Université Paris Cité, Paris, France

Uday Yanamandra, MD, DM^1,2, Harikrishnan Premdeep, MD^3*, J Muthukrishnan, MD^4*, Narendra Kotwal^5*, Pankaj Malhotra, MD^6,7,8, Velu Nair, MBBS, MD^9,10 and Shaji Kumar, MD^11,12

¹Internal Medicine and Hematology, Armed Forces Medical College, Pune, IND
²Internal Medicine and Hematology, Armed Forces Medical College, Pune, India
³INTERNAL MEDICINE, ARMED FORCES MEDICAL COLLEGE, PUNE, India
⁴Internal Medicine, Armed Forces Medical College, Pune, India
⁵Armed Forces Medical College, Pune, India
⁶Postgraduate Institute of Medical Education and Research, Chandigarh, India
⁷Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
⁸Department of Clinical Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India
⁹Apollo Hospitals Ahmedabad, Detrojrampura, Gujarat, India
¹⁰Apollo Hospitals Ahmedabad, Detrojrampura, Gujarat, IND
¹¹Division of Hematology, Mayo Clinic, Rochester, MN
¹²Mayo Clinic, Rochester, MN

Yannick Dieudonné^1*, Clement Gourguechon^2*, Romain Stammler, MD^3*, Florence Delestre^4*, Boris Sorin^5*, Bertrand Dunogué^4*, Guillaume Dumas^6*, Guillemette Fouquet, MD, PhD^7*, Anne Marie Ronchetti^8*, Romain Paule^9*, Pascal Meliani^10*, Nathalie Pansu^11*, Rodolphe Buzele^12*, Robin Noel, MD^13*, Jehane Fadlallah^14*, Emilie Corvilain, MD^15*, Marion Malphettes^16*, Laurence Gerard, MD^17*, Veronique Meignin^18*, Constance Guillaud^19*, Antoine Dossier^20*, Jeremie Dion^21*, Eric Oksenhendler^14*, Lionel Galicier^22* and David Boutboul, MD, PhD^3,23*

¹Strasbourg University Hospital, Strasbourg, FRA
²Amiens University Hospital, Amiens, France
³Department of Hematology, Hôpital Cochin, AP-HP, Université Paris Cité, Paris, France
⁴Internal Medicine, Hopital Cochin Université Paris Cité, Paris, France
⁵Internal Medicine, Hopital Cochin Université Paris Cité, Paris, FRA
⁶Intensive Care Unit, CHU Grenoble, Grenoble, France
⁷Hematology Department, Hospital Sud Francilien, Corbeil-Essonnes, France
⁸CH Sud Francilien, Hematology Department, Corbeil Essonne, France
⁹Hopital Foch, Suresnes, FRA
¹⁰CH Mayotte, Mayotte, France
¹¹Tropical and Infectious Diseases University Hospital, Montpellier Cedex 5, Franc, Montpellier, FRA
¹²Centre Hospitalier de Saint-Brieuc, Saint-Brieuc, France
¹³Institut Paoli-Calmettes, Marseille, FRA
¹⁴Service d'Immunopathologie Clinique, Saint Louis hospital, AP-HP, Paris, France
¹⁵Hôpital Saint-Louis, APHP, Paris, France
¹⁶Saint Louis Hospital, Paris, France
¹⁷Hôpital Saint-Louis, Paris, France
¹⁸Assistance Publique - Hôpitaux de Paris (APHP), Pathology; Paris University. Paris, Paris, France
¹⁹Hôpital Henri Mondor, Créteil, France
²⁰Internal Medicine, Hôpital Bichat, Paris, France
²¹Toulouse University Hospital, Toulouse, France
²²Centre de Réference National Maladie de Castleman, Paris, France
²³Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute, Paris, France

Louis Williams, MD¹, Danai Dima, MD², Hanny Sawaf, MD^3*, Ali Mehdi, MD, M.Ed.^3*, Daniel Cancilla, MD⁴, Hira Shaikh, MD⁵, Faiz Anwer, MD⁶, Sandra Mazzoni, DO⁷, Beth M. Faiman, PhD, CNP⁶, Jack Khouri, MD⁶, Christy J. Samaras, DO⁸, Jason Valent, MD⁶ and Shahzad Raza, MD⁶

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²University of Washington, Seattle, WA
³Cleveland Clinic Foundation, Cleveland, OH
⁴Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
⁵University of Iowa Caver College of Medicine, Coralville, IA
⁶Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁷Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
⁸Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland

Hassan Kawtharany^1*, Muayad Azzam, MD^2*, Jamil Nazzal, MD^1*, Vishal Kukreti, MD, MSc³, Matthew D. Seftel, MD, FRCP, FRCPC, MPH⁴, Qais Hamarsha, MD^1*, Aseel Alkhader, MD^1*, Tala Khraise, MD^5*, Mohammad Mahmoud AlMasri, MD^6*, Hadi Khaled Abou Zeid, MD^7*, Iktimal Alwan, MD^8*, Mhd Amin Alzabibi, MD^9*, Noor Jaber^1*, Laura Darwish^10*, Faizi Jamal, MD^11*, Noel Dasgupta, MD^12*, Nitasha Sarswat, MD^13*, Alfredo H. De La Torre, MD¹⁴, Maria Adela Aguirre, MD, PhD^15*, Deborah Boedicker^16*, Naresh Bumma, MD¹⁷, Antonia Carroll, MD^18*, Raymond Comenzo, MD¹⁹, Joselle Cook, MBBS²⁰, Angela Dispenzieri, MD²⁰, Jack Khouri, MD²¹, Maria M. Picken, MD, PhD^22*, Shahzad Raza, MD²¹, Nelson Leung, MD²⁰, Vaishali Sanchorawala²³, Hira Shaikh, MD²⁴, Daulath Singh, MD^25* and Reem A Mustafa, MD, PhD, MPH^26*

¹Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
²Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Overland Park, KS
³Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁴Department of Medicine, University of British Columbia, Vancouver, CAN
⁵Northwest Health, Porter County, IN
⁶King Hussein Cancer Center, Amman, Jordan
⁷University of Balamand, Balamand, Lebanon
⁸AdventHealth, Tampa
⁹Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
¹⁰Blue Valley Southwest, Kansas city
¹¹Division of Cardiology, Department of Medicine, City of Hope National Medical Center, Duarte, CA
¹²Indiana University School of Medicine, Indianapolis, IN
¹³Advanced Heart Failure, Mechanical Circulatory Support and Transplantation, Division of Cardiology, The University of Chicago, Chicago, IL
¹⁴QEII Health Sciences Centre, Halifax, NS, CAN
¹⁵Internal Medicine Department, Hospital Italiano de Buenos Aires, BUENOS AIRES, AL, ARG
¹⁶Mackenzie’s Mission, Great Falls, VA
¹⁷The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
¹⁸Department of Neurology and Neurophysiology, St Vincent’s Hospital, Sydney, AUS
¹⁹Tufts Medical Center, Boston, MA
²⁰Division of Hematology, Mayo Clinic, Rochester, MN
²¹Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²²Loyola University Medical Center, Maywood, IL
²³Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
²⁴Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
²⁵Mission Cancer + Blood, Des Moines, IA
²⁶Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, KS

Muayad Azzam, MD^1*, Hassan Kawtharany^2*, Jamil Nazzal, MD^2*, Vishal Kukreti, MD, MSc³, Matthew D. Seftel, MD, FRCP, FRCPC, MPH⁴, Aseel Alkhader, MD^2*, Qais Hamarsha, MD^2*, Tala Khraise, MD^5*, Mohammad Mahmoud AlMasri, MD^6*, Hadi Khaled Abou Zeid, MD^7*, Iktimal Alwan, MD^8*, Noor Jaber^2*, Mohammad Fraitekh^9*, Noel Dasgupta, MD^10*, Raymond Comenzo, MD¹¹, Faizi Jamal, MD^12*, Maria Adela Aguirre, MD, PhD^13*, Deborah Boedicker^14*, Naresh Bumma, MD¹⁵, Antonia Carroll, MD^16*, Joselle Cook, MBBS¹⁷, Alfredo H. De La Torre, MD¹⁸, Angela Dispenzieri, MD¹⁷, Jack Khouri, MD¹⁹, Nelson Leung, MD¹⁷, Maria M. Picken, MD, PhD^20*, Shahzad Raza, MD¹⁹, Vaishali Sanchorawala²¹, Hira Shaikh, MD²², Nitasha Sarswat, MD^23*, Daulath Singh, MD^24* and Reem A Mustafa, MD, PhD, MPH^25*

¹Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Overland Park, KS
²Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
³Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁴Department of Medicine, University of British Columbia, Vancouver, CAN
⁵Northwest Health, Porter County, IN
⁶King Hussein Cancer Center, Amman, Jordan
⁷University of Balamand, Balamand, Lebanon
⁸AdventHealth, Tampa
⁹Blue Valley West, Overland Park, KS
¹⁰Indiana University, Bloomington, IN
¹¹Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
¹²Division of Cardiology, Department of Medicine, City of Hope National Medical Center, Duarte, CA
¹³Internal Medicine Department, Hospital Italiano de Buenos Aires, BUENOS AIRES, AL, ARG
¹⁴Mackenzie’s Mission, Great Falls, VA
¹⁵The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
¹⁶Department of Neurology and Neurophysiology, St Vincent’s Hospital, Sydney, AUS
¹⁷Division of Hematology, Mayo Clinic, Rochester, MN
¹⁸QEII Health Sciences Centre, Halifax, NS, CAN
¹⁹Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²⁰Loyola University Medical Center, Maywood, IL
²¹Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
²²Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
²³Advanced Heart Failure, Mechanical Circulatory Support and Transplantation, Division of Cardiology, The University of Chicago, Chicago, IL
²⁴Mission Cancer + Blood, Des Moines, IA
²⁵Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, KS

Alexa Loncharich, MD¹, Mark Fiala, PhD^2*, Julie Fortier, PhD^2*, Keith Stockerl-Goldstein, MD³, Ravi Vij, MD, MBA³, Mark A. Schroeder, MD³, Mark Zaydman, MD, PhD⁴, Michael Slade, MD, MS³ and Mariya Liyasova, PhD^5*

¹Washington University School of Medicine in St. Louis, St Louis, MO
²Division of Oncology, Washington University School of Medicine, Saint Louis, MO
³Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁴Division of Pathology, Washington University School of Medicine, St Louis, MO
⁵Rapid Novor Inc., Kitchener, ON, Canada

Abdullah Faisal Deen^1*, Qaiser Bashir, MD¹, Neeraj Y. Saini, MD¹, Yosra M. Aljawai, MD, MS², Chitra Hosing, MD¹, Uday Popat, MD¹, Melody R. Becnel, MD³, Gregory P. Kaufman, MD^3*, Sheeba K. Thomas, MD³, Donna M. Weber, MD⁴, Robert Z. Orlowski, MD, PhD⁴, Elizabeth J. Shpall, MD¹, Richard E. Champlin, MD¹, Muzaffar H. Qazilbash, MD¹ and Samer A. Srour, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Sophiya S Sami^1*, Qaiser Bashir, MD¹, Neeraj Y. Saini, MD¹, Yosra M. Aljawai, MD, MS¹, Chitra Hosing, MD¹, Uday Popat, MD¹, Melody R. Becnel, MD², Gregory P. Kaufman, MD^2*, Sheeba K. Thomas, MD², Donna M. Weber, MD², Robert Z. Orlowski, MD, PhD², Richard E. Champlin, MD¹, Elizabeth J. Shpall, MD¹, Muzaffar H. Qazilbash, MD¹ and Samer A. Srour, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Omer Ashruf^1*, Ali Mushtaq, MD², Faiza Zakaria, MBBS^3*, Razwana Khanam, MD^4* and Faiz Anwer, MD⁵

¹College of Medicine, Northeast Ohio Medical University, Solon, OH
²Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
³Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan
⁴Department of Hematology & Oncology, Medical University of South Carolina, Charleston, SC
⁵Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Jamil Nazzal, MD^1*, Muayad Azzam, MD^2*, Hassan Kawtharany^3*, Vishal Kukreti, MD, MSc⁴, Matthew D. Seftel, MD, FRCP, FRCPC, MPH^5,6, Aseel Alkhader, MD^3*, Tala Khraise, MD^7*, Qais Hamarsha, MD^3*, Hadi Khaled Abou Zeid, MD^8*, Iktimal Alwan, MD^9*, Mohammad Mahmoud AlMasri, MD^10*, Noor Jaber^3*, Vaishali Sanchorawala¹¹, Joselle Cook, MBBS¹², Jack Khouri, MD¹³, Angela Dispenzieri, MD¹², Maria M. Picken, MD, PhD^14*, Maria Adela Aguirre, MD, PhD^15*, Hira Shaikh, MD¹⁶, Shahzad Raza, MD¹⁷, Antonia Carroll, MD^18*, Deborah Boedicker^19*, Naresh Bumma, MD²⁰, Raymond Comenzo, MD²¹, Noel Dasgupta, MD^22*, Daulath Singh, MD^23*, Alfredo H. De La Torre, MD²⁴, Nitasha Sarswat, MD^25*, Nelson Leung, MD¹², Faizi Jamal, MD^26* and Reem A Mustafa, MD, PhD, MPH^27*

¹Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, KANSAS CITY, AL
²Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Overland Park, KS
³Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
⁴Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵CancerCare, Vancouver, BC, Canada
⁶Department of Medicine, University of British Columbia, Vancouver, CAN
⁷Northwest Health, Porter County, IN
⁸University of Balamand, Balamand, Lebanon
⁹AdventHealth, Tampa
¹⁰King Hussein Cancer Center, Amman, Jordan
¹¹Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
¹²Division of Hematology, Mayo Clinic, Rochester, MN
¹³Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
¹⁴Loyola University Medical Center, Maywood, IL
¹⁵Internal Medicine Department, Hospital Italiano de Buenos Aires, BUENOS AIRES, AL, ARG
¹⁶Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
¹⁷Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Overland Park, KS
¹⁸Department of Neurology and Neurophysiology, St Vincent’s Hospital, Sydney, AUS
¹⁹Mackenzie’s Mission, Great Falls, VA
²⁰The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
²¹Tufts Medical Center, Boston, MA
²²Indiana University, Bloomington, IN
²³Mission Cancer + Blood, Des Moines, IA
²⁴QEII Health Sciences Centre, Halifax, NS, CAN
²⁵Advanced Heart Failure, Mechanical Circulatory Support and Transplantation, Division of Cardiology, The University of Chicago, Chicago, IL
²⁶Division of Cardiology, Department of Medicine, City of Hope National Medical Center, Duarte, CA
²⁷Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, KS

Hassan Kawtharany^1*, Muayad Azzam, MD^2*, Jamil Nazzal, MD^1*, Vishal Kukreti, MD, MSc³, Matthew D. Seftel, MD, FRCP, FRCPC, MPH⁴, Qais Hamarsha, MD^1*, Aseel Alkhader, MD^1*, Tala Khraise, MD^5*, Mohammad Mahmoud AlMasri, MD^6*, Hadi Khaled Abou Zeid, MD^7*, Iktimal Alwan, MD^8*, Mhd Amin Alzabibi, MD^9*, Noor Jaber^1*, Alfredo H. De La Torre, MD¹⁰, Noel Dasgupta, MD^11*, Nitasha Sarswat, MD^12*, Faizi Jamal, MD^13*, Maria Adela Aguirre, MD, PhD^14*, Deborah Boedicker^15*, Naresh Bumma, MD¹⁶, Antonia Carroll, MD^17*, Raymond Comenzo, MD¹⁸, Joselle Cook, MBBS¹⁹, Angela Dispenzieri, MD¹⁹, Jack Khouri, MD²⁰, Maria M. Picken, MD, PhD^21*, Shahzad Raza, MD²⁰, Nelson Leung, MD¹⁹, Vaishali Sanchorawala²², Hira Shaikh, MD²³, Daulath Singh, MD^24* and Reem A Mustafa, MD, PhD, MPH^25*

¹Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
²Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Overland Park, KS
³Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁴Department of Medicine, University of British Columbia, Vancouver, CAN
⁵Northwest Health, Porter County, IN
⁶King Hussein Cancer Center, Amman, Jordan
⁷University of Balamand, Balamand, Lebanon
⁸AdventHealth, Tampa
⁹Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
¹⁰QEII Health Sciences Centre, Halifax, NS, CAN
¹¹Indiana University School of Medicine, Indianapolis, IN
¹²Advanced Heart Failure, Mechanical Circulatory Support and Transplantation, Division of Cardiology, The University of Chicago, Chicago, IL
¹³Division of Cardiology, Department of Medicine, City of Hope National Medical Center, Duarte, CA
¹⁴Internal Medicine Department, Hospital Italiano de Buenos Aires, BUENOS AIRES, AL, ARG
¹⁵Mackenzie’s Mission, Great Falls, VA
¹⁶The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
¹⁷Department of Neurology and Neurophysiology, St Vincent’s Hospital, Sydney, AUS
¹⁸Tufts Medical Center, Boston, MA
¹⁹Division of Hematology, Mayo Clinic, Rochester, MN
²⁰Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²¹Loyola University Medical Center, Maywood, IL
²²Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
²³Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
²⁴Mission Cancer + Blood, Des Moines, IA
²⁵Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, KS

Efstathios Kastritis, MD, PhD^1*, Giovanni O. Palladini, MD, PhD², Meletios-Athanasios Dimopoulos¹, Arnaud Jaccard, MD, PhD^3*, Giampaolo Merlini, MD, PhD^2*, Foteini Theodorakakou, MD^1*, Despina Fotiou, MD^1*, Monique C Minnema^4*, Ashutosh D. Wechalekar, MBBS, DM, FRCP, FRCPath⁵, Stavros Golfinopoulos, MD, MSc, MBA^6*, Nasia Antoniou, MSc, PhD^6*, Giorgos Psarros, MSc^6*, Pieter Sonneveld, MD⁷ and Stefan Schonland^8*

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Amyloidosis Research and Treatment Center, University of Pavia, Pavia, Italy
³Referral Center for AL Amyloidosis, Limoges, France
⁴Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
⁵Clinical Haematology, Cancer Division, University College London Hospital, London, United Kingdom
⁶Health Data Specialists, Dublin, Ireland
⁷Erasmus MC Cancer Institute, Rotterdam, Netherlands
⁸Medical Department V, Amyloidosis Center, University of Heidelberg, Heidelberg, Germany

Mario Nuvolone, MD, PhD^1,2*, Ute Hegenbart, MD^3*, Bruno Paiva, PhD^4*, Monique C. Minnema⁵, Enkelejda Miho^6,7,8*, Marta Lasa^9*, Paolo Milani, MD, PhD^1,2, Alain van Mil, PhD^10*, Marish I. F. Oerlemans, MD^11,12*, Jan Kruta^7*, Ramon Lecumberri Villamediana, MD, PhD^13*, Alice Nevone, PhD^1,2*, Luca Arcaini, MD^2,14*, Francesca Gay, MD, PhD¹⁵, Francesco Di Raimondo, MD, Prof¹⁶, Pellegrino Musto^17*, Eloisa Riva, MD, MEd¹⁸, Mohammed Aljama, MBBS, FRCPC^19*, Krzysztof Jamroziak, MD, PhD^20*, Roberta Shcolnik Szor, MD^21*, Mathias Brehon, MD^22*, Giampaolo Merlini, MD, PhD^1,2*, Stefan Schonland^3* and Giovanni O. Palladini, MD, PhD^1,2

¹Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²Department of Molecular Medicine, University of Pavia, Pavia, Italy
³Medical Department V, Amyloidosis Center, University of Heidelberg, Heidelberg, Germany
⁴Department of Hematology, Centre for Applied Medical Research, Cancer Center Clinica Universidad de Navarra, University of Navarra, IdiSNA, CIBERONC, Pamplona, Spain
⁵Department of Hematology, UMC Utrecht, Utrecht, Netherlands
⁶SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
⁷School of Life Sciences, FHNW University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland
⁸aiNET GmbH, Basel, Switzerland
⁹Clinica Universidad De Navarra, Centro De Investigacion Medica Aplicada (CIMA),, Pamplona, Spain
¹⁰Laboratory of Experimental Cardiology, Regenerative Medicine Center, UMC Utrecht, Utrecht, Netherlands
¹¹Department of Cardiology, UMC Utrecht, Utrecht, Netherlands
¹²Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart), Utrecht, Netherlands
¹³Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBER-ONC CB16/12/00369, Pamplona, Spain, Spain, Pamplona, Spain
¹⁴Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
¹⁵Division of Hematology 1, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
¹⁶Haematology, AOU Policlinico G. Rodolico-San Marco, University School of Medicine, Catania, Italy, CATANIA, ITA
¹⁷Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine,and Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Bari, Italy
¹⁸University of the Republic, Hospital De Clínicas Dr. Manuel Quintela, Montevideo, Uruguay
¹⁹Department of Oncology, McMaster University, Hamilton, Canada
²⁰Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warszawa, Poland
²¹Hospital Nove de Julho, DASA, São Paulo, Brazil
²²Médipôle Lyon-Villeurbanne, Villeurbanne, FRA

Aditi Sharma, MD¹, Joel Topf, MD^2*, Christiane A. Houde, BS^1*, Cathy Galasso^1*, Sarah Phillips, BS^1*, Carmen Mitteer^1*, Amanda Guido^1*, Lori McFadden^2*, Katelyn Staub, RN^1*, Amy Blake, NP^1*, Joseph Ellul, NP^1*, Andrew Kin, MD¹, Craig Emmitt Cole, MD¹, Abhinav Deol, MD^1*, Joseph Schiavi, R.Ph.^1*, Seongho Kim, PhD^1* and Jeffrey A. Zonder, MD ³

¹Karmanos Cancer Institute/Wayne State University, Detroit, MI
²Wayne State University, Detroit, MI
³Karmanos Cancer Institute, Detroit, MI